Google may invest in Jawbone; Tandem raises $56M;

@FiercePharma: ICYMI from FiercePharmaManufacturing: Impax reports significant jump in revenues as it gets plant problems behind it. Article | Follow @FiercePharma

@EricPFierce: FDA problems continue to pile up at Wockhardt Indian plant banned from shipping to the US. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: ICYMI earlier: Pfizer, Novartis get MenB ACIP nod--but not the one they're really after. More from FierceVaccines | Follow @CarlyHFierce

> Google ($GOOG) reportedly is considering an investment into fitness tracking player Jawbone in what would be yet another foray into healthcare. Story

> Mobility robotics player Bionik Laboratories has raised $6.2 million in a private placement. More

> The long-awaited Apple Watch is slated to debut potentially at a mysterious upcoming Apple ($AAPL) event on March 9. Story

> Tandem Diabetes Care ($TNDM) expects $56.3 million in net proceeds from a follow-on offering. Release

> Cardiac molecular diagnostics company Transgenomic anticipates $6.2 million in net proceeds from a recent equity offering. More

Medical Device News

@FierceMedDev: Exact Sciences beefs up sales and reimbursement efforts for colon cancer Dx. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Boston Scientific launches upgraded endoscope, says it will reduce repeat procedures. Article | Follow @VarunSaxena2

@EmilyWFierce: Vigilant Biosciences reels in $5.5M for oral cancer test. More from FierceDiagnostics | Follow @EmilyWFierce

> Nikon to buy optical imaging player Optos for $400M in med tech expansion bid. Story

> UnitedHealth to require prior authorization for gynecological procedures amid morcellator pushback. More

> Device for remote and autonomous management of Parkinson's being tested in Europe. Article

Biotech News

@FierceBiotech: From @FiercePharmAsia, Novartis' Japan unit hit with a 15-day sales ban. Article | Follow @FierceBiotech

@JohnCFierce: ICYMI: Vitae slammed as another BACE inhibitor trips and Boehringer halts Alzheimer's study. Report | Follow @JohnCFierce

@DamianFierce: While $MRK and $ACT embrace antibiotics, $AZN is tiptoeing out. Report | Follow @DamianFierce

> Viehbacher wades into the startup world, joining PureTech in his first post-Sanofi move. News

> Chiasma hauls in $70M to write its post-Roche future. Report

> Ablynx gets caught in Merck KGaA's R&D retreat. Story

> Stealthy Lyric Pharma bags $20M for its gastro drug. Article

Suggested Articles

J.D. Power aims to set the benchmarks in telehealth satisfaction with a new study due this November.

Atomwise plans to screen up to 10 billion virtual compounds for therapies against childhood cancer in collaboration with chemical supplier Enamine.

The Chan Zuckerberg Initiative set aside $68 million for over three dozen projects in an effort to map out every type of cell in the body.